Holen Sie sich die Stockscreener-App
0.6832
1.74%
-0.0121
Vorhandelsmarkt:
.69
0.0068
+1.00%
Tenaya Therapeutics Inc Aktie (TNYA) Neueste Nachrichten
A heart-disease biotech will meet investors at two September conferences - Stock Titan
Israel Englander group takes passive stake in Tenaya Therapeutics (TNYA) - Stock Titan
Tenaya Therapeutics (TNYA) Falls 3.85% to $0.70 as Shares Approach Critical SupportSynthetic Long - vinanet.vn
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301 - MarketBeat
Tenaya therapeutics CEO Ali Faraz sells $15.8k in company shares By Investing.com - Investing.com Australia
Tenaya therapeutics CMO Tingley Whittemore sells $5,267 in stock By Investing.com - Investing.com Nigeria
Tenaya therapeutics CEO Ali Faraz sells $15.8k in company shares - Investing.com
Tenaya therapeutics CMO Tingley Whittemore sells $5,267 in stock - Investing.com
Tenaya Therapeutics (NASDAQ:TNYA) CEO Sells $15,784.72 in Stock - MarketBeat
Tenaya Therapeutics, Inc. SEC Filing (Aug 18, 2026) - Stock Titan
GSA Capital Partners LLP Makes New $1.97 Million Investment in Tenaya Therapeutics, Inc. $TNYA - MarketBeat
Tenaya Therapeutics (TNYA) Q2 2026 Earnings: EPS Misses by 186.94% as Clinical-Stage Pipeline Drives Wider-Than-Expected LossRevenue Recognition Risk - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
Transcript : Tenaya Therapeutics, Inc. Presents at Canaccord Genuity's 46th Annual Growth Conference, Aug-11-2026 12 - marketscreener.com
Tenaya Therapeutics (TNYA) Institutional Ownership 2026 - MarketBeat
Tenaya Therapeutics (TNYA) Drops 4% to $0.73 — Testing Crucial Support ZoneADD Alert - Vinanet
TNYA Q2 2026 Earnings: Wider-Than-Expected Loss as Shares Climb on Pipeline OptimismDiluted EPS Report - Vinanet
Tenaya Therapeutics (TNYA) Rises 1.89% to $0.75, Holding Above $0.71 SupportIndex Put Call - vinanet.vn
Tenaya Therapeutics at Canaccord Genuity conference: q4 catalysts loom By Investing.com - Investing.com Canada
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Renaissance Technologies LLC Increases Stock Holdings in Tenaya Therapeutics, Inc. $TNYA - MarketBeat
HC Wainwright Has Positive Outlook of TNYA FY2026 Earnings - MarketBeat
Q3 Earnings Forecast for TNYA Issued By HC Wainwright - MarketBeat
H.C. Wainwright Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $3 - Moomoo
William Blair Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating - moomoo.com
Tenaya Therapeutics (NASDAQ:TNYA) Issues Quarterly Earnings Results - MarketBeat
Tenaya Therapeutics (TNYA) Gains 5.81% as Biotech Stock Holds Above Critical $0.74 SupportZero Gamma Level - dars.gov.et
Tenaya Therapeutics, Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Tenaya Therapeutics Q2 net loss widens on impairment charge - TradingView
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Tenaya Therapeutics (TNYA) to Post Earnings on Wednesday - MarketBeat
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Tenaya CFO Eric Hyllengren to Speak at Boston Conference - Stock Titan
Tenaya Therapeutics (TNYA) Slips to $0.74 as Key Support at $0.70 Comes into FocusAAII Neutral - vinanet.vn
Tenaya Therapeutics Inc (TNYA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tenaya Therapeutics Inc (TNYA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TNYA|Tenaya Therapeutics Inc|Price:0.769|Chg%:-0.006 - TradingKey
Tenaya Therapeutics Inc (TNYA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tenaya Therapeutics Inc (TNYA) Cash Flow - TradingKey
Tenaya Therapeutics, Inc. Revenue Breakdown – NASDAQ:TNYA - TradingView
Tenaya Therapeutics Inc (TNYA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tenaya Therapeutics Inc (TNYA) Institutional Confidence - TradingKey
Tenaya Therapeutics (TNYA) Holds Near Support as Micro-Cap Biotech Seeks DirectionPut Support - vinanet.vn
Tenaya Therapeutics (TNYA) Edges Higher Amid Consolidation Near SupportThrowback Trade - vinanet.vn
Tenaya Therapeutics Q1 2026 Earnings: Slight EPS Miss as Pre-Revenue Biotech Advances Heart Disease Pipeline - dars.gov.et
Tenaya Therapeutics Inc. (TNYA) Q1 2026 Earnings: EPS Slightly Misses Estimates, Stock Declines as Pre-Revenue Biotech Continues Pipeline DevelopmentRevenue Per Share - dars.gov.et
Tenaya’s new CFO gets options on 1.65M shares, with a $0.8365 exercise price - Stock Titan
Tenaya Therapeutics (TNYA) CFO files first Form 3 ownership report - Stock Titan
Tenaya Therapeutics (TNYA) grants CFO 1,650,000 stock options - Stock Titan
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Tenaya Therapeutics (TNYA) Slides to $0.86 as Bearish Pressure Tests SupportMomentum ETF - vinanet.vn
Tenaya Therapeutics Inc. (TNYA) Q1 2026 Earnings: Slight EPS Miss Overshadowed by Pipeline ProgressRevenue Surprise History - dars.gov.et
Tenaya Therapeutics, Inc. Podcast | TNYA Podcasts & Related Content - finance.biggo.com
TNYA News | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Tenaya Therapeutics (TNYA) - The Globe and Mail
Piper Sandler reiterates Overweight on Tenaya stock, $40 target - Investing.com
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):